This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hasnat, K. Articles by Yacoub, M. H. Search for Related Content PubMed PubMed Citation Articles by Hasnat, K. Articles by Yacoub, M. H. Related Collections Health policy and outcome research Valvular heart disease CV surgery: valvular disease

(Circulation. 1999;100:II-42.)
© 1999 American Heart Association, Inc.

Surgery for Valvular Heart Disease

Patient Outcome and Valve Performance Following a Second Aortic Valve Homograft Replacement

K. Hasnat, FRCS; E. J. Birks, MRCP; J. Liddicoat, MD, MB, ChB; J. K. F. Hon, MBChB; S. Edwards, RNC; S. Glennon, RNC; M. H. Yacoub, FRS

From the Academic Department of Cardiac Surgery, Royal Brompton and Harefield NHS Trust, London, United Kingdom.

Correspondence to Sir Magdi Yacoub, FRS, Professor of Cardiothoracic Surgery, Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, United Kingdom.

Background—Homograft valves offer many advantages; however, there is concern about their use in second aortic valve replacement because of the complexity of the procedure and the possibility of accelerated degeneration.

Methods and Results—One hundred and forty-four patients underwent a second aortic homograft replacement between 1973 and 1997 (mean follow-up 6.5±5 years, range 1 to 20 years). Eighty-three were male, and 61 were female, aged 17 to 77 years, mean 49.0 years. All patients had undergone previous aortic valve replacement with a homograft. The indication for reoperation was aortic regurgitation in 75 patients (52.1%), aortic stenosis in 28 (19.4%), and mixed aortic valve disease in 41 (28.5%). Root replacement was performed in 54 patients (38%) and subcoronary in 90 (62.5%). Early mortality was 3.4%. The actuarial survival rate was 93% and 82% at 5 and 10 years, respectively. Freedom from tissue degeneration was 96% and 80% at 5 and 10 years, respectively, and freedom from reoperation was 97% and 82% at 5 and 10 years, respectively.

Conclusions—This study shows that a second aortic valve homograft replacement results in good early and long-term survival. Accelerated degeneration does not occur. Left ventricular performance is improved, and earlier surgery could further improve outcome, indicating that an aortic homograft is a safe, durable option for patients requiring a second aortic valve replacement.

Key Words: : valves • aorta • regurgitation